On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
FridayOct 13, 2017 11:34 am

CannabisNewsBreaks – International Endeavors Corp. (IDVV) Enters MOU with Kubby Cryogenics, Inc. to Expand Medical Cannabis Line

International Endeavors (OTC: IDVV) this morning said that it has signed a memorandum of understanding (MOU) with Kubby Cryogenics, Inc. Per the agreement, Kubby Cryogenics will seek to patent medical grade cannabis strains that are genetically profiled to treat specific diseases. The agreement also states that Steve Kubby will immediately become CEO of International Endeavors. Kubby Cryogenics has assembled a team of top scientists and geneticists to continue developing the company’s proprietary cryogenics products. "We will create a dispensary system for legal medical cannabis states standardizing the patient centered, consultation approach while presenting an enticing line of Adult Use products…

Continue Reading

FridayOct 13, 2017 11:16 am

CannabisNewsBreaks – India Globalization Capital (NYSE: IGC) Achieves Breakthrough with Potential to Prevent, Combat Alzheimer’s

India Globalization Capital (NYSE MKT: IGC), a first mover in the cannabis-based combination therapy space, recently announced that it is readying a line of cannabis-based medical dispensary products that target Alzheimer’s disease (http://nnw.fm/l2NJw). IGC is engineering genetic cell lines which demonstrate that, at various concentrations of tetrahydrocannabinol (THC), the protein Aβ decreases as much as 40 percent without neuron damage. An article discussing this reads: “This compelling in vitro data, and the promise it shows as a preventative and powerful treatment against Alzheimer’s, makes IGC a company with valuation growth potential for investors. The commercial potential for an Alzheimer’s treatment…

Continue Reading

ThursdayOct 12, 2017 2:27 pm

CannabisNewsBreaks – Why Skinvisible, Inc. (SKVI) is Worth Watching in a $65B Market

Skinvisible, Inc. (OTCQB: SKVI), through its wholly owned subsidiary Skinvisible Pharmaceuticals, Inc., is an R&D company offering its patented Invisicare® technology, which can be used to revitalize or create new medical or skincare products, thus enabling companies that license Skinvisible’s formulations to sell their own patented products and ward off generic rivals. A high-performance topical and transdermal delivery system, Invisicare enhances the delivery of drugs and other ingredients to and through the skin utilizing Skinvisible’s innovative formula and process for combining hydrophilic and hydrophobic polymers into stable complexes in water emulsions.  An article discussing this reads: “A prescription dermatology product…

Continue Reading

ThursdayOct 12, 2017 9:30 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is Frontrunner in the Delivery of Non-Psychoactive Cannabinoids

Lexaria Biosciences Corp. (CSE: LXX) (OTCQB: LXRP), a biosciences company that has developed delivery technologies to improve absorption of bioactive compounds, has enhanced the ability of cannabinoid-products companies to deliver active ingredients to the body with its patent-protected technology. This technology is already being applied to the use of non-psychoactive cannabinoids, yielding a high-absorption hemp oil formula that is a source of omega and fatty acids, and patents are pending for tetrahydrocannabinol (THC) and other psychoactive cannabinoids along with nicotine and nonsteroidal anti-inflammatory drugs. An article discussing this reads: “The patent awarded to LXRP for the delivery of all non-psychoactive…

Continue Reading

ThursdayOct 12, 2017 9:30 am

CannabisNewsBreaks – Why Cannabis Market Investors are Keeping an Eye on EVIO, Inc. (EVIO)

EVIO, Inc. (OTCQB: EVIO), through its EVIO Labs division, is a national leader in providing accredited analytical testing, scientific research and advisory services to the regulated cannabis industry and provides state-mandated ancillary services required for ensuring the safety and quality of the cannabis supply in the United States. During the past two years, EVIO Labs has performed more than 50,000 tests and has evolved from operating one laboratory in Oregon to having nine labs that span California, Oregon, Colorado, Massachusetts and Florida. An article discussing this reads: “EVIO Labs is driving the cannabis testing industry by providing clients nationwide with…

Continue Reading

ThursdayOct 12, 2017 9:23 am

CannabisNewsBreaks – PotNetwork Holding, Inc. (POTN) Subsidiary Records 20.9% Monthly Revenue Growth in August, Strengthens Advisory Board

PotNetwork Holding, Inc. (OTC: POTN) this morning announced that its wholly owned subsidiary, Diamond CBD, Inc., achieved record-breaking revenues for the month of August. Diamond CBD’s August revenues totaled $1.76 million, marking an increase of 20.9 percent over the prior month. “As the summer comes to a close, we continue to be very happy with our growth on every level,” Maria Gomez, regional vice president of sales for Diamond CBD, stated in the news release. “In consideration of our recent trend of monthly record breaking growth, we prepare for a whole new level of corporate growth.” In a separate news…

Continue Reading

WednesdayOct 11, 2017 2:35 pm

CannabisNewsBreaks – Emblem Corp. (TSX.V: EMC) (OTC: EMMBF) Sharpens Focus on Potentially Game-Changing Sustained Release Cannabinoid Formulation

Licensed Canadian cannabis cultivation company Emblem Corp. (TSX.V: EMC) (OTC: EMMBF) recently entered into a collaboration and licensing agreement with Canntab Therapeutics Limited to collaborate on the preclinical formulation, clinical development, regulatory approval, manufacturing and commercialization of Canntab’s patent-pending oral sustained release cannabinoid formulation. The agreement grants Emblem the exclusive right to Canntab’s patents and expertise in Canada to develop, commercialize, use, sell and offer—but not import or export—the product, which will be sold under the Emblem brand. An article discussing this reads: “For pharmaceutical ingredients that are typically short-acting, like cannabinoids, sustained release formulations enable dosage schedules that are…

Continue Reading

WednesdayOct 11, 2017 2:34 pm

CannabisNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Scales Up in Preparation for Canada’s Impending 2018 Recreational Cannabis Legalization

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) was one of the first companies to obtain a cannabis production license in Canada, and it continues going strong among the country’s limited number of licensed growers—only 62 to date. The company’s high-tech indoor growing environment—with every facet of the growing, curing and harvesting process controlled and monitored by computer—yields a high-quality product that is clean, steady and repeatable—something the company can effectively leverage should recreational cannabis legalization go through in 2018. An article discussing this reads: “Focused on scaling its operations and distinguishing itself through its proprietary organic and pesticide-free growing technology,…

Continue Reading

WednesdayOct 11, 2017 10:04 am

CannabisNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Launches Cryptocurrency Daily Video Newscast

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced the launch of the first cryptocurrency daily video newscast in the Chinese language broadcast from the NYSE. Titled ‘Bitcoin Multimillionaire’, the video newscast aims to provide timely information and analysis regarding all aspects of the emerging digital currency world. “Many Chinese investors are seeking information and education related to the cryptocurrency sector,” Warren Wang, founder and CEO of CIIX, stated in the news release. “Similar to U.S. stocks, as the price of digital currency, such as Bitcoin, continues to increase, Chinese people all over the world are taking notice and…

Continue Reading

WednesdayOct 11, 2017 9:37 am

CannabisNewsBreaks – SinglePoint, Inc. (SING) Announces Completion of $4M Funding Round

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced the completion of a $4 million round of funding, $1.2 million of which has already been collected. This total includes a $600,000 investment from United American HealthCare Corp. (OTC: UAHC). With this funding in place, SinglePoint is positioned to aggressively develop and complete its bitcoin payments solution while pursuing additional acquisition opportunities in the thriving cannabis industry. “After months of negotiation, we are beyond excited to close this deal and go after some larger deals that we have in our pipeline,” Greg Lambrecht, CEO of SinglePoint, stated in the news…

Continue Reading

Contact us: 303.498.7722